← Back to Analyst Consensus 
CUE Buy
Cue Biopharma, Inc.
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | B. Riley Securities | initiate | — → Buy | — | 54% |
| Aug 25, 2025 | LUCID CAPITAL MARKETS | initiate | — → Buy | $4 | 34% |
| Apr 2, 2025 | Citizens Capital Markets | reiterate | Market Outperform → Market Outperform | $2 | 49% |
| Aug 20, 2024 | Stifel | maintain | Buy → Buy | $4 | 53% |
| Jul 26, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $2 | 53% |
| Jul 26, 2024 | Piper Sandler | maintain | Overweight → Overweight | $3 | 54% |
| Apr 9, 2024 | Stifel | maintain | Buy → Buy | $8 | 53% |
| Apr 9, 2024 | Oppenheimer | maintain | Outperform → Outperform | $10 | 52% |
| Apr 3, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $8 | 54% |
| Mar 13, 2024 | Jefferies | initiate | — → Buy | $6 | 52% |
| Nov 6, 2023 | Piper Sandler | maintain | Overweight → Overweight | $8 | 54% |
| Jun 15, 2023 | Stifel | reiterate | Buy → Buy | $8 | 53% |
| May 15, 2023 | JMP Securities | reiterate | Outperform → Outperform | $15 | 53% |
| Mar 22, 2023 | Stifel | maintain | — → Buy | $8 | 53% |
| Mar 22, 2023 | Oppenheimer | reiterate | — → Outperform | $10 | 52% |
| Nov 21, 2022 | Piper Sandler | initiate | — → Overweight | $7 | 54% |
| Aug 24, 2022 | Oppenheimer | maintain | — → Outperform | $10 | 52% |
| Mar 21, 2022 | Oppenheimer | maintain | — → Outperform | $26 | 52% |
| Mar 18, 2022 | Craig-Hallum | maintain | — → Buy | $26 | 54% |
| Nov 24, 2020 | Berenberg | initiate | — → Buy | $30 | 29% |
| May 20, 2020 | Stifel | maintain | — → Buy | $30 | 53% |
| May 20, 2020 | Oppenheimer | maintain | — → Outperform | $32 | 52% |
| Apr 21, 2020 | Stifel | maintain | — → Buy | $25 | 53% |
| Apr 9, 2020 | Stifel | initiate | — → Buy | $21 | 53% |
| Mar 6, 2020 | JMP Securities | maintain | — → Outperform | $30 | 53% |
| Feb 25, 2020 | Oppenheimer | initiate | — → Outperform | $27 | 52% |
| Jan 28, 2020 | BTIG | initiate | — → Buy | $26 | 52% |
| Jan 22, 2020 | JMP Securities | initiate | — → Market Outperform | $22 | 53% |
| Jul 26, 2019 | Baird | initiate | — → Outperform | $13 | 55% |
Price Target Trend
May 3, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days